Pharmacotherapy of Complex Obesity: A Case Based Approach
CME/CE Expiration Date: 4/25/2024*
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.
More than one-third of adults in the United States suffer from the chronic disease of obesity. While lifestyle modification is the cornerstone of any weight loss treatment, weight loss achieved through lifestyle modifications alone is often limited and difficult to maintain. Therefore, pharmacotherapy, when used appropriately in combination with lifestyle modification plays an important role in the treatment of obesity and improves both short-term and long-term outcomes.
The session will offer a case-based, practical guide to current strategies in obesity management across various conditions such as drug induced weight gain, prediabetes and type 2 diabetes, polycystic ovary syndrome, depression, binge eating, other psychiatric conditions, cardiovascular disease, suboptimal post bariatric surgery weight loss or post bariatric surgery weight regain, and monogenic obesity. Finally, the session will discuss the treatment of the patient with overweight/obesity who also has prediabetes or diabetes and recommend appropriate diabetes medications to prescribe that consider a weight centric approach.
The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
The Obesity Medicine Association designates this internet enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
|Access Date||Quiz Result||Score||Actions|